Position in ABVX
as of Mar 31, 2026
· filed Apr 9, 2026
Position Value
$360,774
-$16,280 QoQ
Shares Held
3,240
+15.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Avior Wealth Management, LLC holds $6,163,519 across 10 Biotechnology names. ABVX ranks #7 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,054 | $1,363,733 | |
| 2 | ASND |
Ascendis Pharma A/S
|
5,463 | $1,249,551 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,399 | $1,080,923 | |
| 4 | INSM |
INSMED Inc
|
3,994 | $653,098 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
8,647 | $502,477 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
4,650 | $404,410 | |
| 7 | ABVX |
Abivax S.A.
This page
|
3,240 | $360,774 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,327 | $323,550 |
All Filings in ABVX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $360,774 | 3,240 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $377,054 | 2,796 | Shares | Sole | 2026-01-06 | |
| No filing history on record for this holder in this stock. | ||||||